A phase I study of the safety and immunogenicity of a SARS recombinant DNA plasmid vaccine, VRC-SRSDNA015-00-VP, in healthy adult volunteers

Trial Profile

A phase I study of the safety and immunogenicity of a SARS recombinant DNA plasmid vaccine, VRC-SRSDNA015-00-VP, in healthy adult volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Coronavirus vaccine; VRC SRSDNA015 00 VP
  • Indications Severe acute respiratory syndrome
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 25 Nov 2008 Results published in Vaccine, reported in a Vical media release.
    • 23 Aug 2007 Status changed from in progress to completed.
    • 11 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top